Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

Rhea-AI Summary

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) will provide an update at two virtual investor conferences. The first is Citi’s 2022 Virtual Healthcare Conference on February 24, 2022, at 11:00am ET, followed by Cowen's 42nd Annual Health Care Conference on March 9, 2022, at 2:50pm ET. Both presentations will be webcast live, with archives available for 30 days on Tandem's Investor Center website. Tandem is focused on enhancing diabetes care through innovative products like the t:slim X2 insulin pump, which features remote software updates and integrated continuous glucose monitoring.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences:

• Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 11:00am Eastern Time (8:00am Pacific Time), and
• Cowen 42^nd Annual Health Care Conference on Wednesday, March 9, 2022 at 2:50pm Eastern Time (11:50am Pacific Time).

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220211005378/en/

Media Contact:

Steve Sabicer

714-907-6264

ssabicer@thesabicergroup.com



Investor Contact:

Susan Morrison

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

What is the date and time of Tandem Diabetes Care's presentation at Citi’s 2022 Virtual Healthcare Conference?

Tandem Diabetes Care will present on February 24, 2022, at 11:00am Eastern Time.

When will Tandem Diabetes Care present at the Cowen 42nd Annual Health Care Conference?

The presentation at the Cowen 42nd Annual Health Care Conference is scheduled for March 9, 2022, at 2:50pm Eastern Time.

Where can I watch the live webcast of Tandem Diabetes Care's investor presentations?

The live webcast can be accessed on Tandem Diabetes Care’s Investor Center website in the 'Events & Presentations' section.

What products does Tandem Diabetes Care focus on?

Tandem Diabetes Care focuses on insulin delivery and diabetes technology, including their flagship t:slim X2 insulin pump.

How long will the archive of Tandem Diabetes Care's presentations be available?

The archive recording of the presentations will be available for 30 days.